Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Stem Cell Therapy for Osteoarthritis - A Pipeline Analysis Report 2017 - Research and Markets

Research and Markets
Posted on: 03 Nov 17

The "Stem Cell Therapy for Osteoarthritis - A Pipeline Analysis Report" report has been added to Research and Markets' offering.

The global osteoarthritis market is expected to grow at a CAGR of 8.55% over the period of 2014-2019.

The stem cell therapy for osteoarthritis pipeline analysis report includes ongoing clinical and non-clinical trends in the global stem cell therapy for osteoarthritis. Majority of the pipeline therapeutics are in early stages of development. There is no cure for the disease, but treatments are available to manage the symptoms. A long-lasting and less-frequent dose can impact overall osteoarthritis market.

The expected growth is because of increasing awareness of osteoarthritis and increasing diagnosis rates, rising older population, and increasing cases of obesity. Osteoarthritis is directly related to obesity, with approximately 37% of osteoarthritis patients suffering from obesity.

Major companies

  • Mesoblast
  • Regeneus
  • U.S. Stem Cell
  • Anterogen
  • Asterias Biotherapeutics

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: STEM CELL THERAPY FOR OSTEOARTHRITIS: AN INSIGHT

  • Introduction

PART 05: MAJOR REGULATORY AUTHORITIES

  • US
  • Europe
  • Japan
  • Australia
  • China

PART 06: PIPELINE LANDSCAPE

PART 07: COMPARATIVE ANALYSIS

  • Late-stage molecule (Phase III)
  • Mid-stage molecules (Phase II and Phase I/II)
  • Early-stage molecules (Phase I and pre-clinical)
  • Inactive molecules

PART 08: INDICATION ANALYSIS

PART 09: THERAPEUTIC ASSESSMENT BY THERAPY

  • Therapeutic assessment based on therapy

PART 10: THERAPEUTIC ASSESSMENT BY ROA

  • Therapeutic assessment based on RoA

PART 11: THERAPEUTIC ASSESSMENT BY STAGE AND ROA

  • Therapeutic assessment based on RoA in various stages of development

PART 12: KEY COMPANIES

For more information about this report visit https://www.researchandmarkets.com/research/tzn2j5/stem_cell_therapy

View source version on businesswire.com: http://www.businesswire.com/news/home/20171103005597/en/

Business Wire
www.businesswire.com

Last updated on: 03/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.